immunai
Immunai is seeking a Senior Computational Biologist to lead data analysis projects in immuno-oncology and autoimmune diseases, working closely with pharma, biotech, and academic partners. The role involves designing and executing multi-omics data analysis, collaborating with multidisciplinary teams, and communicating research findings.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2019
Immunai is a biotechnology company focused on decoding the immune system by mapping it at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. The company partners with top biopharmaceutical companies and research institutions to support drug discovery and development through solutions including target discovery, preclinical evaluation, and clinical trial optimization. Its platform leverages multiomic data, a large harmonized single-cell immune database (AMICA), and advanced machine learning to deliver actionable insights for drug development strategies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for immunai.
Computational Biologist
UMass Chan Medical School
Postdoctoral Researcher in Computational Immuno-oncology
University of Helsinki
Senior Principal Scientist, Portfolio In silico Evidence Lead, Computational Biology
Digital Biology
Senior Scientist, Therapeutics & Translational Bioinformatics
Moderna
Senior Computational Biologist
Gordian Biotechnology
Computational Biologist
Guidehouse